Atreca Stock Price - BCEL

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
After Hours
Last Trade
Last $ 10.57 ◊ 0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
Atreca Inc BCEL NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.30 -2.76% 10.57 11.10 10.13 10.83 10.87 18:00:00
Bid Price Ask Price Spread Spread % News
9.59 14.15 4.56 32.23% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
1,369 115,594 $ 10.47 $ 1,210,247 120,286 9.59 - 23.65
Last Trade Time Type Quantity Stock Price Currency
16:22:25 formt 157 $ 10.57 USD

Atreca Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 295.41M 27.95M -17.16 - 27.58M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 7.00 1.30%

more financials information »

Atreca News

Date Time Source News Article
8/26/201916:05GlobeNewswire Inc.Atreca Announces Appointment of Dr. Lindsey Rolfe to its..
8/13/201916:05GlobeNewswire Inc.Atreca Reports Second Quarter 2019 Financial Results and..
7/11/201908:00GlobeNewswire Inc.Atreca Further Strengthens Management Team with Appointment..
6/19/201921:40GlobeNewswire Inc.Atreca Announces Pricing of Initial Public Offering

Latest BCEL Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BCEL Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week10.0711.139.5910.5658,2780.504.97%
1 Month13.7914.249.5911.5273,035-3.22-23.35%
3 Months13.1023.659.5914.29106,105-2.53-19.31%
6 Months19.9023.659.5915.37114,328-9.33-46.88%
1 Year19.9023.659.5915.37114,328-9.33-46.88%
3 Years19.9023.659.5915.37114,328-9.33-46.88%
5 Years19.9023.659.5915.37114,328-9.33-46.88%

Atreca Description

Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism of action and target derived from an antibody identified using its discovery platform.
Your Recent History
NASDAQ
BCEL
Atreca
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191023 05:47:12